Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Building a balanced search formula for pharmacovigilance and literature monitoring

Posted on March 21st, 2017 by in Pharmacovigilance

Adverse drug reactions are an important risk for patient safety and have significant impact on the costs of health systems. A rise in number of diseases has consequently led to a rise in number of drug consumption, which has also brought about an increase in the number of adverse drug events and drug toxicity cases. Continue reading “Building a balanced search formula for pharmacovigilance and literature monitoring” »

5 Most popular Pharmacovigilance blog posts of 2016

Posted on January 26th, 2017 by in Pharmacovigilance

The most-read pharmacovigilance posts of the year really demonstrate the breadth and depth of issues that professionals in this area are dealing with. In these blogs, authors tackled subjects as varied as leadership needs, compliance metrics, the role of scientific literature in identifying adverse events Continue reading “5 Most popular Pharmacovigilance blog posts of 2016” »

Outsourcing PV: Keys for a Successful Partnership

Posted on January 25th, 2017 by in Pharmacovigilance

This is the last of the blog series on outsourcing PV activities. At this stage, you have identified what PV activities to outsource, the due diligence is complete and the best vendor is identified. Continue reading “Outsourcing PV: Keys for a Successful Partnership” »

Outsourcing PV: Selecting your Partner

Posted on January 23rd, 2017 by in Pharmacovigilance

Once you know what functions and expertise you want to keep in house and what are the PV activities you want to outsource, the next challenge will be to identify potential partners and pick-up the one which will fit your PV needs for the years to come. Continue reading “Outsourcing PV: Selecting your Partner” »

  1. 1
  2. 2